Cadrenal Therapeutics, Inc. Common Stock (CVKD)
$11.20 $0.16 (1.42%) 10:23 PM 12/14/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$18.58M -
Day's Range
$11.11 - $11.82 -
Volume
63,804 -
52 Week Low / High
$5.40 - $32.55 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
CVKD's Dividend
Analyists Ranking
- 1
- Strong Buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $3.00
- Target Price
Company News
-
CVKD: Cadrenal Therapeutics and Abbott Collaborate on Novel Anticoagulant for LVAD Patients — Aug 7th, 2024
NASDAQ:CVKD Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing tecarfarin, has announced a collaborative effort with Abbott (NYSE:ABT) to advance this novel anticoagulant for patients with left ventricular assist devices (LVADs). This partnership aims to imp...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$